Polymorphism of excision repair genes XPD, XRCC1, and hOGG1 in the population of the republic of Belarus and its impact on carcinogenesis

Russian Journal of Genetics: Applied Research

Volumn 5, Issue 2, 2015, Pages 141-154

  Ramaniuk, V P ^a   Nikitchenko, N V ^a   Savina, N V ^a   Kuzhir, T D ^a   Goncharova, R I ^a  

^a INSTITUTE OF GENETICS AND CYTOLOGY   (Belarus)

Author keywords

bladder cancer; DNA excision repair; gene polymorphism; repair genes XPD, XRCC1, hOGG1

Indexed keywords

XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BELARUS; BLADDER CANCER; CANCER RECURRENCE; CARCINOGENESIS; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; EXCISION REPAIR; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HOGG1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

EID: 84928643209     PISSN: 20790597     EISSN: 20790600     Source Type: Journal    
DOI: 10.1134/S2079059715020094     Document Type: Article

References (115)

1. Andrew, A.S., Karagas, M.R., Nelson, H.H., et al., Hum. Hered., 2008, vol. 65, pp. 105–118.
2. Arizono, K., Osada, Y., and Kuroda, Y., Jpn. J., Clin. Oncol., 2008, vol. 38, pp. 186–191.
3. Babich, P.N., Chubenko, A.V., and Lapach, S.N., Application of modern statistical methods in practice of clinical researches. Series 3. Odds ratio: concept, calculation and interpretation, Ukr. Med. Chasopis, 2005, vol. 2, no. 46, pp. 113–119.
4. Bau, D.T., Wu, H.C., Chiu, C.F., et al., Anticancer Res., 2007, vol. 27, pp. 2893–2896.
5. Belev, N.F., The role of genetic factors in the etiopathogenesis of colon cancer, in Materialy III s“ezda onkologov i radiologov SNG (Proc. III Congr. Oncologists and Radiologists of CIS), Minsk, May 25–28, 2004, Part I, pp. 64–68.
6. Berquist, B.R., Singh, D.K., Fan, J., et al., Nucleic Acids Res., 2010, vol. 38, pp. 5023–5035.
7. Best, B.P., Rejuvenation Res., 2009, vol. 12, pp. 199–208.
8. Bonita, R., Beaglehole, R., and Kjellström, T., Basic Epidemiology, 2nd ed., World Health Organization, 2006.
9. Brem, R. and Hall, J., Nucleic Acids Res., 2005, vol. 33, pp. 2512–2520.
10. Caldecott, K.W., Aoufouchi, S., Johnson, P., and Shall, S., Nucleic Acids Res., 1996, vol. 24, pp. 4387–4394.
11. Capellá, G., Pera, G., Sala, N., et al., Int. J. Epidemiol, 2008, vol. 37, pp. 1316–1325.
12. Chang, C.H., Hsiao, C.F., Chang, G.C., et al., Am. J. Epidemiol., 2009, vol. 170, pp. 695–702.
13. Chang, J.S., Wrensch, M.R., Hansen, H.M., et al., Carcinogenesis, 2009, vol. 30, pp. 78–87.
14. Chen, L., Elahi, A., Pow-Sang, J., et al., J. Urol., 2003, vol. 170, pp. 2471–2474.
15. Chen, M., Kamat, A.M., Huang, M., et al., Carcinogenesis, 2007, vol. 28, pp. 2160–2165.
16. Cho, E.Y., Hildesheim, A., Chen, C.J., et al., Cancer Epidemiol. Biomarkers Prev., 2003, vol. 12, pp. 1100–1104.
17. David-Beabes, G.L. and London, S.J., Lung Cancer, 2001, vol. 34, pp. 333–339.
18. De Ruyck, K., Szaumkessel, M., De Rudder, I., et al., Mutat. Res., 2007, vol. 631, pp. 101–110.
19. Debniak, T., Scott, R.J., Huzarski, T., et al., Breast Cancer Res. Treat., 2006, vol. 98, pp. 209–215.
20. Della-Maria, J., Hegde, M.L., McNeill, D.R., et al., J. Biol. Chem., 2012, vol. 287, pp. 39233–39244.
21. Duell, E.J., Holly, E.A., Bracci, P.M., et al., Cancer Res., 2002, vol. 62, pp. 4630–4636.
22. Falagan-Lotsch, P., Rodrigues, M.S., Esteves, V., et al., Genet. Mol. Biol., 2009, vol. 32, pp. 255–259.
23. Figueiredo, J.C., Knight, J.A., Briollais, L., et al., Cancer Epidemiol. Biomarkers Prev., 2004, vol. 13, pp. 583–591.
24. Figueroa, J.D., Malats, N., Real, F.X., et al., Hum. Genet., 2007, vol. 121, pp. 233–242.
25. Försti, A., Angelini, S., Festa, F., et al., Oncol. Rep., 2004, vol. 11, pp. 917–922.
26. Franekova, M., Halasova, E., Bukovska, E., et al., Urol. Oncol., 2008, vol. 26, pp. 1–8.
27. García-Closas, M., Malats, N., Real, F.X., et al., Cancer Epidemiol. Biomarkers Prev., 2006, vol. 15, pp. 536–542.
28. Global’nyi opros vzroslogo naseleniya o potreblenii tabaka (Global Adult Tobacco Survey (GATS)), Russian Federation, Country Report, 2009. Cited May 13, 2013. http://www.who.int/tobacco/ru-tfi-gatsrussian-countryreport.pdf
29. Goode, E.L., Ulrich, C.M., and Potter, J.D., Cancer Epidemiol. Biomarkers Prev., 2000, vol. 11, pp. 1513–1530.
30. Guan, P., Huang, D., Yin, Z., and Zhou, B., Asian Pac. J. Cancer Prev., 2011, vol. 12, pp. 1067–1072.
31. Haigis, M.C. and Yankner, B.A., Mol. Cell, 2010, vol. 40, pp. 333–344.
32. Han, J., Colditz, G.A., Liu, J.S., and Hunter, D.J., Cancer Epidemiol. Biomarkers Prev., 2005, vol. 14, pp. 1539–1544.
33. Han, J., Hankinson, S.E., De Vivo, I., et al., Cancer Res., 2003, vol. 63, pp. 8536–8541.
34. Hansen, R.D., Sørensen, M., Tjønneland, A., et al., Mutat. Res., 2007, vol. 619, pp. 68–80.
35. Hazra, T.K., Das, A., Das S., et al., DNA Repair (Amst.), 2007, vol. 6, pp. 470–480.
36. Hoeijmakers, J.H.J., DNA Repair Mechanisms: Impact on Human Diseases and Cancer, Jean-Michel, H. Vos, Ed., New York: Springer-Verlag, 1995, pp. 126–150.
37. Hou, S.M., Fält, S., Angelini, S., et al., Carcinogenesis, 2002, vol. 23, pp. 599–603.
38. Hu, Z., Ma, H., Chen, F., et al., Cancer Epidemiol. Biomarkers Prev., 2005, vol. 14, pp. 1810–1818.
39. Huang, M., Dinney, C.P., Lin, X., et al., Cancer Epidemiol. Biomarkers Prev., 2007, vol. 16, pp. 84–91.
40. Huang, W.Y., Berndt, S.I., Kang, D., et al., Cancer Epidemiol. Biomarkers Prev., 2006, vol. 15, pp. 306–311.
41. Hung, R.J., Brennan, P., Canzian, F., et al., J. Natl. Cancer Inst., 2005, vol. 97, pp. 567–576.
42. Ito, H., Hamajima, N., Takezaki, T., et al., J. Epidemiol., 2002, vol. 12, pp. 258–265.
43. Ito, H., Matsuo, K., Hamajima, N., et al., Carcinogenesis, 2004, vol. 25, pp. 1395–1401.
44. Janković, S. and Radosavljević, V., Tumori, 2007, vol. 93, pp. 4–12.
45. Ji, C., Liu, Z., Chen, H., et al., BMC Cancer, 2012, vol. 12, p. 335.
46. Ji, Y.B., Tae, K., Lee, Y.S., et al., Clin. Exp. Otorhinolaryngol., 2010, vol. 3, pp. 42–47.
47. Jiao, L., Hassan, M.M., Bondy, M.L., et al., Cancer Lett., 2007, vol. 245, pp. 61–68.
48. Justenhoven, C., Hamann, U., Pesch, B., et al., Cancer Epidemiol. Biomarkers Prev., 2004, vol. 13, pp. 2059–2064.
49. Karahalil, B., Emerce, E., Koçer, B., et al., Arh. Hig. Rada Toksikol., 2008, vol. 59, pp. 241–250.
50. Kim, E.J., Jeong, P., Quan, C., et al., Urology, 2005, vol. 65, pp. 70–75.
51. Kim, S.U., Park, S.K., Yoo, K.Y., et al., Pharmacogenetics, 2002, vol. 12, pp. 335–338.
52. Kohno, T., Kunitoh, H., Toyama, K., et al., Cancer Sci, 2006, vol. 97, pp. 724–728.
53. Kohno, T., Shinmura, K., Tosaka, M., et al., Oncogene, 1998, vol. 16, pp. 3219–3225.
54. Kuzhir, T.D., DNA repair in pathology: chromosome instability syndromes, Vestsi NAN Belarusi, Ser. Med. Navuk, 2009, no. 2, pp. 96–102.
55. Laine, J.P., Mocquet, V., Bonfanti, M., et al., DNA Repair (Amst), 2007, vol. 6, pp. 1264–1270.
56. Lan, Q., Mumford, J.L., Shen, M., et al., Carcinogenesis, 2004, vol. 25, pp. 2177–2181.
57. Lavender, N.A., Komolafe, O.O., Benford, M., et al., Prostate, 2010, vol. 70, pp. 113–119.
58. Le Marchand, L., Donlon, T., Lum-Jones, A., et al., Cancer Epidemiol. Biomarkers Prev., 2002, vol. 11, pp. 409–412.
59. Lee, J.M., Lee, Y.C., Yang, S.Y., et al., Int. J. Cancer, 2001, vol. 95, pp. 240–246.
60. Li, C., Hu, Z., Liu, Z., et al., Cancer Epidemiol. Biomarkers Prev., 2006, vol. 15, pp. 2526–2532.
61. Liang, G., Xing, D., Miao, X., et al., Int. J. Cancer, 2003, vol. 105, pp. 669–673.
62. López-Cima, M.F., González-Arriaga, P., Garcia-Casto, L., et al., BMC Cancer, 2007, vol. 7, p. 162.
63. Lovatt, T., Alldersea, J., Lear, J.T., et al., Hum. Mutat., 2005, vol. 25, pp. 353–359.
64. Matullo, G., Dunning, A.M., Guarrera, S., et al., Carcinogenesis, 2006, vol. 27, pp. 997–1007.
65. Mechanic, L.E., Millikan, R.C., Player, J., et al., Carcinogenesis, 2006, vol. 27, pp. 1377–1385.
66. Metsola, K., Kataja, V., Sillanpää, P., et al., Breast Cancer Res., 2005, vol. 7, pp. 987–997.
67. Misra, R.R., Ratnasinghe, D., Tangrea, J.A., et al., Cancer Lett., 2003, vol. 191, pp. 171–178.
68. Mittal, R.D., Mandal, R.K., and Gangwar, R., Mech. Ageing Dev., 2012, vol. 133, pp. 127–132.
69. Miyaishi, A., Osawa, K., Osawa, Y., et al., J. Exp. Clin. Cancer Res., 2009, vol. 28, p. 10.
70. Moreno, V., Martin, M.L., Bosch, F.X., et al., Am. J. Epidemiol., 1996, vol. 143, pp. 293–300.
71. Moullan, N., Cox, D.G., Angèle, S., et al., Cancer Epidemiol. Biomarkers Prev., 2003, vol. 12, pp. 1168–1174.
72. Narter, K.F., Ergen, A., Agaçhan, B., et al., Anticancer Res., 2009, vol. 29, pp. 1389–1393.
73. Nelson, H.H., Kelsey, K.T., Mott, L.A., and Karagas, M.R., Cancer Res., 2002, vol. 62, pp. 152–155.
74. Nock, N.L., Cicek, M.S., Li, L., et al., Carcinogenesis, 2006, vol. 27, pp. 1842–1848.
75. Okasaka, T., Matsuo, K., Suzuki, T., et al., J. Hum. Genet., 2009, vol. 54, pp. 739–745.
76. Pakakasama, S., Sirirat, T., Kanchanachumpol, S., et al., Pediatr. Blood Cancer, 2007, vol. 48, pp. 16–20.
77. Park, J., Chen, L., Tockman, M.S., et al., Pharmacogenetics, 2004, vol. 14, pp. 103–109.
78. Park, J.Y., Lee, S.Y., Jeon, H.S., et al., Cancer Epidemiol. Biomarkers Prev., 2002, vol. 11, pp. 23–27.
79. Peltomäki, P., Human Mol. Genet., 2001, vol. 10, pp. 735–740.
80. Polyakov, S.M., Levin, L.F., Shebeko, N.G., and Shcherbina, O.F., Zlokachestvennye novoobrazovaniya v Belarusi (Malignant Neoplasms in Belarus), Sachek, M.M. and Sukonko, O.G., Eds., Minsk: BelCMT, 2011.
81. Qian, B., Zhang, H., Zhang, L., et al., Lung Cancer, 2011, vol. 73, pp. 138–146.
82. Sambrook, J., Fritsch, E.F., and Maniatis, T., Molecular Cloning: A Laboratory Manual, 2nd ed., New York: Cold Spring Harbor Laboratory Press, 1989.
83. Sanyal, S., Festa, F., Sakano, S., et al., Carcinogenesis, 2004, vol. 25, pp. 729–734.
84. Savina, N.V., Smal, M.P., Kuzhir, T.D., et al., Mutat. Res., 2012, vol. 748, pp. 21–28.
85. Schabath, M.B., Delclos, G.L., Grossman, H.B., et al., Cancer Epidemiol. Biomarkers Prev., 2005, vol. 14, pp. 878–884.
86. Settheetham-Ishida, W., Yuenyao, P., Natphopsuk, S., et al., Asian Pac. J. Cancer Prev., 2011, vol. 12, pp. 963–966.
87. Shen, M.R., Jones, I.M., and Mohrenweiser, H., Cancer Res., 1998, vol. 58, pp. 604–608.
88. Shu, X.O., Cai, Q., Gao, Y.T., et al., Cancer Epidemiol. Biomarkers Prev., 2003, vol. 12, pp. 1462–1467.
89. Smith, T.R., Levine, E.A., Perrier, N.D., et al., Cancer Epidemiol. Biomarkers Prev., 2003, vol. 12, pp. 1200–1204.
90. Sørensen, M., Raaschou-Nielsen, O., Hansen, R.D., et al., Free Radic. Res., 2006, vol. 40, pp. 885–891.
91. Sugimura, H., Kohno, T., Wakai, K., et al., Cancer Epidemiol. Biomarkers Prev., 1999, vol. 8, pp. 669–674.
92. Teebor, G.W., in DNA Repair Mechanisms: Impact on Human Diseases and Cancer, Jean-Michel, H. Vos, Ed., New York: Springer Verlag, 1995, pp. 99–123.
93. Tudek, B., Mol. Aspects, Med., 2007, vol. 28, pp. 258–275.
94. Turner, N., Tutt, A., and Ashworth, A., Curr. Opin. Farmacol., 2005, vol. 5, pp. 388–393.
95. Tutt, A. and Ashworth, A., Trends Mol. Med., 2002, vol. 8, pp. 571–576.
96. Vodicka, P., Stetina, R., Polakova, V., et al., Carcinogenesis, 2007, vol. 28, pp. 657–664.
97. Wang, F., Chang, D., Hu, F.L., et al., Cancer Epidemiol. Biomarkers Prev., 2008, vol. 17, pp. 507–517.
98. Wang, W., Wu, Y.J., and Wu, Y.M., Carcinogen. Teratogen. Mutagen., 2005, vol. 17, pp. 101–103.
99. Wei, B., Zhou, Y., Xu, Z., et al., PLoS One, 2011, vol. 6, p. 11. Posted November 17, 2011, cited May 12, 2013. doi: 10.1371/journal.pone.0027545
100. Weiss, J.M., Goode, E.L., Ladiges, W.C., and Ulrich, C.M., Mol. Carcinogen., 2005a, vol. 42, pp. 127–141.
101. Weiss, J.M., Weiss, N.S., Ulrich, C.M., et al., Cancer Epidemiol. Biomarkers Prev., 2005b, vol. 14, pp. 2524–2530.
102. Wikman, H., Risch, A., Klimek, F., et al., Int. J. Cancer, 2000, vol. 88, pp. 932–937.
103. Wu, X., Gu, J., Grossman, H.B., et al., Am. J. Hum. Genet., 2006, vol. 78, pp. 464–479.
104. Xing, D., Qi, J., Miao, X., et al., Int. J. Cancer, 2002, vol. 100, pp. 600–605.
105. Yamane, A., Kohno, T., Ito, K., et al., Carcinogenesis, 2004, vol. 25, pp. 1689–1694.
106. Ye, W., Kumar, R., Bacova, G., et al., Carcinogenesis, 2006, vol. 27, pp. 1835–1841.
107. Yu, H.P., Wang, X.L., Sun, X., et al., Cancer Genet. Cytogenet., 2004, vol. 154, pp. 10–15.
108. Yu, M.W., Yang, S.Y., Pan, I.J., et al., J. Natl. Cancer Inst., 2003, vol. 95, pp. 1485–1488.
109. Yun, S.J., Ha, Y.S., Chae, Y., et al., Ann. Oncol., 2012, vol. 23, pp. 401–405.
110. Zhang, J., Dhakal, I.B., Greene, G., et al., Urology, 2010, vol. 75, pp. 779–785.
111. Zhang, X., Miao, X., Liang, G., et al., Cancer Res., 2005, vol. 65, pp. 722–726.
112. Zhong, D., Li, G., Long, J., et al., Sci. Rep., 2012a, vol. 2, p. 548. Posted July 31, 2012, cited May 12, 2013. doi: 10.1038/srep005482
113. Zhong, D.Y., Chu, H.Y., Wang, M.L., et al., Genet. Mol. Res., 2012b, vol. 11, pp. 3490–3496.
114. Zhou, W., Liu, G., Miller, D.P., et al., Cancer Res., 2002, vol. 62, pp. 1377–1381.
115. Zhou, W., Liu, G., Miller, D.P., et al., Cancer Epidemiol. Biomarkers Prev., 2003, vol. 12, pp. 359–365.